trending Market Intelligence /marketintelligence/en/news-insights/trending/pzrw01hlrfwdkvcfsz-vqa2 content esgSubNav
In This List

Immune Design director resigns

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Immune Design director resigns

Immune Design Corp. said Peter Svennilson resigned as the company's director, effective Aug. 31.

Svennilson joined the company's board in March 2013. Immune Design noted that his resignation was not due to any disagreement with the company's operations, policies or practices.

Seattle-based Immune Design is an immunotherapy company developing in vivo cancer treatments.